Uploaded November 2026 | Updated November 2026, 3 hours ago
Can prostate cancer continue to progress after radioactive seed treatment?
Dr. Stephen Petteruti discusses a 2025 study involving 120 men who received brachytherapy. He highlights a reported 23.6% rate of pathological progression after three years.
He uses the findings to emphasize why patients should understand both the potential benefits and limitations of treatment before making a decision.
The reported progression rate comes from the study discussed and shouldn't be interpreted as the expected outcome for every patient.
Watch the full episode of Intellectual Medicine for more on brachytherapy and prostate cancer treatment decisions.
#Brachytherapy #ProstateCancer #CancerProgression #ProstateCancerResearch #CancerTreatment #Shorts
Can prostate cancer continue to progress after radioactive seed treatment?
Dr. Stephen Petteruti discusses a 2025 study involving 120 men who received brachytherapy. He highlights a reported 23.6% rate of pathological progression after three years.
He uses the findings to emphasize why patients should understand both the potential benefits and limitations of treatment before making a decision.
The reported progression rate comes from the study discussed and shouldn't be interpreted as the expected outcome for every patient.
Watch the full episode of Intellectual Medicine for more on brachytherapy and prostate cancer treatment decisions.
#Brachytherapy #ProstateCancer #CancerProgression #ProstateCancerResearch #CancerTreatment #Shorts










